Cargando…

Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up

Clinical psychological factors may predict medical diseases. Anxiety level has been associated with osteoporosis, but its role on bone mineral density (BMD) change is still unknown. This study aimed to investigate the association between anxiety levels and both adherence and treatment response to or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martino, Gabriella, Bellone, Federica, Vicario, Carmelo M., Gaudio, Agostino, Caputo, Andrea, Corica, Francesco, Squadrito, Giovanni, Schwarz, Peter, Morabito, Nunziata, Catalano, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346074/ https://www.ncbi.nlm.nih.gov/pubmed/34360437 http://dx.doi.org/10.3390/ijerph18158144

Ejemplares similares

Interrelations between clinical-psychological features and bone mineral density changes in post-menopausal women undergoing anti-osteoporotic treatment: a two-year follow-up
por: Martino, Gabriella, et al.
Publicado: (2023)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
por: Martino, Gabriella, et al.
Publicado: (2020)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Bellone, Federica, et al.
Publicado: (2021)

As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration
por: Martino, Gabriella, et al.
Publicado: (2019)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients
por: Catalano, Antonino, et al.
Publicado: (2022)

SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings
por: Catalano, Antonino, et al.
Publicado: (2020)

The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review
por: Martino, Gabriella, et al.
Publicado: (2020)

Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life
por: Martino, Gabriella, et al.
Publicado: (2020)

Alexithymia and asthma: a systematic review
por: Silvestro, Orlando, et al.
Publicado: (2023)

An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man
por: Bellone, Federica, et al.
Publicado: (2023)

Alexithymia and Inflammatory Bowel Disease: A Systematic Review
por: Martino, Gabriella, et al.
Publicado: (2020)

Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients
por: Misof, B.M., et al.
Publicado: (2017)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome
por: Di Bari, Flavia, et al.
Publicado: (2021)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience
por: Gaudio, Agostino, et al.
Publicado: (2019)

Editorial: Psychological Factors as Determinants of Medical Conditions, Volume II
por: Caputo, Andrea, et al.
Publicado: (2022)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis
por: Fan, Guiyong, et al.
Publicado: (2020)

A Quantum–Classical Model of Brain Dynamics
por: Sergi, Alessandro, et al.
Publicado: (2023)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review
por: Marini, Herbert Ryan, et al.
Publicado: (2023)

Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
por: Lima, Helisane, et al.
Publicado: (2014)

Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach
por: Alito, Angelo, et al.
Publicado: (2023)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

Dopamine and serotonin in fear extinction: some key questions to be addressed
por: Vicario, Carmelo M, et al.
Publicado: (2020)

Effectiveness of bisphosphonates on bone mineral density in osteopenic postmenopausal women: A systematic review and network meta-analysis of randomized controlled trials
por: Dong, Su-li, et al.
Publicado: (2021)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: Sunyecz, John
Publicado: (2008)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
por: Wu, Jiaqi, et al.
Publicado: (2018)

Oral bisphosphonate use and lung cancer incidence among postmenopausal women
por: Tao, M H, et al.
Publicado: (2018)

Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
por: Russo, Giuseppina T., et al.
Publicado: (2017)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis
por: Marozik, Pavel, et al.
Publicado: (2019)

Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?
por: Catalano, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_32iu39hev1rdbqq4m96n6medvs